ACTRN12618001655235招募中1 期
Investigating the pharmacokinetic profile of broccoli sprout extract in women with preeclampsia.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- Female
入选标准
- ••Singleton pregnancy
- •Diagnosis of preeclampsia as defined by the according to the SOMANZ guidelines
- •Gestation greater than 24+0 weeks.
- •Viable fetus, as determined by the treating obstetrician
- •Able to safely continue pregnancy for 48 hours, or longer, as determined by the treating obstetrician
- •Normal mid-trimester morphology scan, with no detectable significant anomalies.
- •Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
- •>18 years of age
- •Clinical hypertension in accordance with SOMANZ guidelines
排除标准
- •Current use of broccoli sprout extract supplement
- •Contraindications to use (eg, intolerance of broccoli)
- •Significant uncertainty in ensuring gestational age is within limits
- •Unwillingness or inability to follow the procedures outlined in the PI and CF
- •Mentally, cognitively or legally incapacitated or ineligible to provide informed consent
- •Co-recruitment/participation in another clinical trial where there is a pharmaceutical or herbal or nutritional intervention (such trial interventions would also include: multi-vitamins, minerals, complementary and alternative medicines)
- •Preexisting inflammatory bowel disease (Ulcerative Colitis and Crohn’s disease)
研究者
相似试验
招募中
2 期
Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African AdultsLay Title: IAVI C100HIV/AIDSPACTR202008822861957International AIDS Vaccine Initiative IAVI176
尚未招募
1 期
Role of Ayurvedic Medicine Brihatsindooradya taila inPsoriasisCTRI/2020/09/027611ATIONAL INSTITUTE OF AYURVEDA
已完成
1 期
Evaluation of the Pharmacokinetics of IPX233 Formulations in Healthy VolunteersAttention Deficit Hyperactivity Disorder (ADHD)Neurological - Other neurological disordersACTRN12613001073796Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.20
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
进行中（未招募）
不适用
A pharmacokinetic and pharmacodynamic study of recombinant human IGF-I (rhIGF-I) in three boys with ALS deficiency, and insulin sensitivity and bone density in patients and heterozygous first-degree relatives. - ALS deficiency: insulin resistance, bone strength & response to rhIGF1ALS (acid label subunit) deficiencyMedDRA version: 12.1Level: LLTClassification code 10056438Term: Growth Hormone DeficiencyEUCTR2010-019296-30-GBniversity Hospital Birmingham NHS Foundation Trust